Oxetoron
Jump to navigation
Jump to search
Template:Oxetoron Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]
For patient information, click here.
![]() | |
| Ball-and-stick model | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Pregnancy category |
|
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| UNII | |
| KEGG | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C21H21NO2 |
| Molar mass | 319.40 g/mol |
| 3D model (JSmol) | |
| |
| (verify) | |
Overview
It's chemical formula is 1-Propanamine, 3-benzofuro[3,2-c][1]benzoxepin-6(12H)-ylidene-N,N-dimethyl-. Oxetorone (USAN) is also known as Oxetorone Fumarate and Oxétorone . It's association with hyperprolactinemia has been described.[1]
Category
Oxetorone is an antimigraine agent.[2]
References
- ↑ Pradalier A (December 1996). "Hyperprolactinaemia and depression induced by oxetorone". Cephalalgia. 16 (8): 560–1. doi:10.1046/j.1468-2982.1996.1608560.x. PMID 8980859.
- ↑ Massiou H (2000). "[Prophylactic treatments of migraine]". Rev. Neurol. (Paris) (in French). 156 Suppl 4: 4S79–86. PMID 11139754.
Categories:
- Pages with script errors
- CS1 maint: Unrecognized language
- Pages with broken file links
- Template:drugs.com link with non-standard subpage
- Drugs with non-standard pregnancy category
- Drugs with non-standard legal status
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Antimigraine drugs
- Drugs
